115 related articles for article (PubMed ID: 5663440)
1. The adjuvant use of pressor amines during cardiac massage.
Rothwell-Jackson RL
Br J Surg; 1968 Jul; 55(7):545-50. PubMed ID: 5663440
[No Abstract] [Full Text] [Related]
2. [Vasopressor action of some adrenergic amines in animals in experimental cardiac arrest].
Pietrobono P; Bragheri R; Berizzi GF
Acta Anaesthesiol; 1968; 19():Suppl 9:65-72. PubMed ID: 5757555
[No Abstract] [Full Text] [Related]
3. Hemodynamics of cardiac massage.
Jackson RE; Freeman SB
Emerg Med Clin North Am; 1983 Dec; 1(3):501-13. PubMed ID: 6396069
[TBL] [Abstract][Full Text] [Related]
4. Interrupting the vicious circle of cardiac arrest.
Jude JR
Geriatrics; 1975 Jul; 30(7):87-91. PubMed ID: 1140571
[No Abstract] [Full Text] [Related]
5. PRESSOR AMINES AND ANGIOTENSIN IN THE TREATMENT OF SHOCK.
UDHOJI VN; WEIL MH; SAMBHI MP
Int Anesthesiol Clin; 1964 Feb; 2():399-419. PubMed ID: 14125018
[No Abstract] [Full Text] [Related]
6. Indications for adrenergic stimulators in shock.
Mills LC; Moyer JH
Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):385-95. PubMed ID: 5566718
[No Abstract] [Full Text] [Related]
7. The roles of methoxamine and norepinephrine in electromechanical dissociation.
Sanders AB
Ann Emerg Med; 1984 Sep; 13(9 Pt 2):835-9. PubMed ID: 6476551
[TBL] [Abstract][Full Text] [Related]
8. The dilemma of vasopressors and vasodilators in the therapy of shock.
Shoemaker WC; Brown RS
Surg Gynecol Obstet; 1971 Jan; 132(1):51-7. PubMed ID: 5538813
[No Abstract] [Full Text] [Related]
9. Use of vasopressor agents to increase somatic blood flow.
Skinner DB; Camp TF; Austen WG
Arch Surg; 1967 May; 94(5):610-8. PubMed ID: 6025897
[No Abstract] [Full Text] [Related]
10. [Pressor amines and cardiogenic shock. An evalution with special reference to the use of noradrenaline].
Hillestad L
Tidsskr Nor Laegeforen; 1965 Nov; 85(21):1621-4. PubMed ID: 5882929
[No Abstract] [Full Text] [Related]
11. The effects of methoxamine and epinephrine on survival and regional distribution of cardiac output in dogs with prolonged ventricular fibrillation.
Roberts D; Landolfo K; Dobson K; Light RB
Chest; 1990 Oct; 98(4):999-1005. PubMed ID: 2209164
[TBL] [Abstract][Full Text] [Related]
12. Vasopressor-cardiotonic drugs in cardiac resuscitation.
Jude JR; Neumaster T; Kfoury E
Acta Anaesthesiol Scand Suppl; 1968; 29():147-63. PubMed ID: 5674565
[No Abstract] [Full Text] [Related]
13. Rational use of drugs for cardiac arrest and after cardiac resuscitation.
Zoll PM
Am J Cardiol; 1971 Jun; 27(6):645-9. PubMed ID: 5088771
[No Abstract] [Full Text] [Related]
14. Vasopressor agents; influence of acidosis on cardiac and vascular responsiveness.
WEIL MH; HOULE DB; BROWN EB; CAMPBELL GS; HEATH C
Calif Med; 1958 Jun; 88(6):437-40. PubMed ID: 13536861
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic effect of 2-amino-6-methylheptane-(+)-camphor-10-sulfonate. Studies in the anesthesized dog].
Tschirkov F; Gross P; Krause E; Jonas D
Arch Kreislaufforsch; 1971; 65(3):162-9. PubMed ID: 5136846
[No Abstract] [Full Text] [Related]
16. Noradrenaline and the kidney: foe, friend, or both?
Matejovic M; Träger K; De Backer D
Intensive Care Med; 2005 Nov; 31(11):1476-8. PubMed ID: 16088409
[No Abstract] [Full Text] [Related]
17. [Sympathomimetic amines of current use. Cardiocirculatory effect in normal dogs. Observations].
Aquino AB
Hospital (Rio J); 1968 Nov; 74(5):1543-52. PubMed ID: 5305332
[No Abstract] [Full Text] [Related]
18. Hypovolemic shock: microcirculatory changes during and after specific therapy.
Stallworth JM; Ramirez A; Barrington BA; Bradham RR
Ann Surg; 1969 May; 169(5):694-703. PubMed ID: 4305267
[No Abstract] [Full Text] [Related]
19. Cardiac pharmacology.
Mendez R; Kabela E
Annu Rev Pharmacol; 1970; 10():291-312. PubMed ID: 4392812
[No Abstract] [Full Text] [Related]
20. Pressor agents in cardiogenic shock.
Corday E; Lillehei RC
Am J Cardiol; 1969 Jun; 23(6):900-10. PubMed ID: 5785170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
